Skip to content
Screener

Erasca, Inc. ERAS Operating Lease Liabilities

Operating Lease Liabilities at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$137.74M+15.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$29.96M-12.2%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$28.25M+10.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$320K
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$0-100%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$3.5M-40.8%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemMarch 31, 2026December 31, 2025
Accrued expenses and other current liabilities19,25022,464
Operating lease liabilities5,2515,066
Total current liabilities26,66428,511
Operating lease liabilities, net of current portion40,70242,073
Other liabilities340399
Total liabilities67,70670,983
Commitments and contingencies (Note 11)
Stockholders' equity:

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s operating lease liabilities?
Erasca, Inc. (ERAS) reported operating lease liabilities of $40.7M in Q1 2026.
How has Erasca, Inc.'s operating lease liabilities changed year-over-year?
Erasca, Inc.'s operating lease liabilities decreased by 11.6% year-over-year, from $46.02M to $40.7M.
What is the long-term trend for Erasca, Inc.'s operating lease liabilities?
Over 5 years (2020 to 2025), Erasca, Inc.'s operating lease liabilities has grown at a 82.0% compound annual growth rate (CAGR), from $2.11M to $42.07M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Ask your AI about Erasca, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude